Litcius/Paper detail

Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan

Teppei Hagino, Risa Hamada, Mai Yoshida, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

2024Clinical Drug Investigation11 citationsDOI

Topics & Concepts

Eczema Area and Severity IndexAtopic dermatitisMedicineErythemaDermatologyFixed-dose combinationRashInternal medicineDermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisAllergic Rhinitis and Sensitization
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan | Litcius